Overall Abstract: The recognition that attenuated clinical symptoms and impaired functioning often precede the onset of psychotic disorders has led to potentially transformative early intervention strategies which could benefit individuals during the prodromal phase through clinical intervention. However, these efforts could present a double-edged sword whereby on one hand earlier treatment could improve symptoms and facilitate recovery, but on the other hand, it could also increase labeling and associated stigma. This set of presentations draws from a diverse set of countries and researcher backgrounds, including peer perspectives to enhance recovery. Our panelists present novel data to address the potential challenges of early intervention strategies and how a better understanding of the stigmatising beliefs and experiences among individuals during the earliest signs of psychotic disorder could improve early intervention efforts. Two presentations use new perspectives to evaluate the perceptions and impact of stigma among prospective cohorts of young people at elevated risk for psychosis. Lawrence Yang uses one of the largest known cohorts of clinical high-risk young people from a multi-site study in the USA to assess the impact of two types of stigma: stigma associated with symptoms and and stigma associated with labelling of the 'high-risk for psychosis' identification. Sara Evans-Lacko uses two unique prospective community cohorts of young people enriched for risk of psychotic disorder from Brazil and the UK and investigates the levels of personal stigma and mental health literacy in relation to psychosis among young people with and without high risk of developing psychotic disorder. She will then present new data on how this relates to intended help-seeking and actual mental health service use among those at-risk for psychotic disorder. Utilizing a different perspective based on changing medical terminology for at-risk states, Danny Koren explores the attributions made by individuals in the general population and mental health professionals when applying 'attenuated pathology' versus 'compromised health' labels to refer to at-risk psychosis states. 
DRIVERS OF STIGMA FOR THE CLINICAL HIGH-RISK STATE FOR PSYCHOSIS-IS
Background: The clinical high-risk state for psychosis syndrome (CHR) offers substantial potential benefits in terms of early identification and treatment for at-risk youth. Early treatment might lead to decreased symptoms, thus leading to reduced symptom-related stigma. However, stigma of the clinical high-risk state for psychosis designation might also initiate further stigma through the label of risk for psychosis. Identifying the effects of these sources of stigma is critical in order to best minimize stigma associated with CHR identification and to facilitate recovery. Methods: Baseline stigma assessments were conducted with 170 clinical high risk state for psychosis individuals in a major, NIH-funded longitudinal study at Columbia University Medical Center, Harvard University Medical Center, and Maine Medical Center from 2012 to 2017. Labeling-related measures of stigma (e.g., "shame of being identified as at psychosis-risk") adapted to the CHR group, and a parallel measure of symptom-related stigma (e.g., "shame of the symptoms associated with CHR") were administered. These measures were examined in relation to outcomes of: a) self-esteem, b) quality of life, and c) social functioning, adjusting for sociodemographics and core CHR symptoms (e.g. attenuated psychotic symptoms). Results: Results indicated that stigma related to symptoms was more strongly associated with all outcomes when compared with shame related to the risk-label. Stigma related to symptoms remained a significant predictor of self-esteem and quality of life even after accounting for stigma related to the risk-label and the effects of sociodemographics and CHR symptoms. Conversely, stigma related to the risk-label was no longer a significant predictor for outcomes after accounting for stigma related to symptoms. Discussion: Overall, symptom-related stigma was a more salient correlate and was independently linked with self-esteem and quality of life even after accounting for the effects of stigma related to the risk-label. These results indicate that treating of symptoms through early identification and treatment may provide major benefit for CHR youth by also alleviating symptom-related stigma. These findings also indicate that CHR services should address stigma associated with symptoms immediately at first identification, as these have substantial effects on psychological and functional outcomes. These findings have implications for guiding implementation of specialized CHR services both in the United States and worldwide. 
CAN THE STIGMATIZING RISKS OF THE 'AT-RISK' STATE BE REDUCED BY RELABELING IT 'HIGH-RISK HEALTH'? PROMISING PILOT
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Background: While there is a wide consensus regarding the potential benefits that early detection and intervention in clinical high-risk (CHR) states for psychosis might offer, application of this paradigm in current mental healthcare systems frequently involves concerns about the iatrogenic impact of stigma on patients, families, institutions, and the society at large. Based on examples from other areas in medicine (e.g., 'high-risk pregnancy' as opposed to 'miscarriage risk syndrome', or 'hearing loss' as opposed to 'attenuated deafness') we have recently hypothesized that restructuring CHR for psychosis states as high-risk states for universal functions (e.g., reality-testing) has the potential to reduce these concerns. The goal of this presentation is to introduce this notion and present pilot data that provide preliminary support for its validity. Methods: In the first study, a sample of 125 adults from the general population read an experimental vignette describing a young adolescent experiencing either mild or severe prodromal symptoms who was randomly assigned a 'psychosis-risk' or 'high-risk reality testing' diagnostic label, and answered questions about stigma, hope, and need for care toward the individual in the vignette. In the second study, a sample of 254 mental health professionals read the same experimental vignette who this time was randomly assigned an 'attenuated psychosis' or 'reality-testing loss' diagnostic label, and answered questions about stigma, hope, and need for care toward the individual in the vignette. Results: In the first study, the 'high-risk reality testing' label elicited significantly higher appraisals of self-image, hope, likelihood of seeking help,
